|
|
Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.
One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.
Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.
The promoters of the company are:
1. Mohan Krishna Mulakala,
2. Dopesh Raja Mulakala,
3. Dr Vyasmurti Madhavrao Shingatgeri,
4. Dr. Soumya Simhadri,
5. Shravan Chintapatla,
6. Karishma Mulakala,
7. Sajan Kiran Mulakala,
8. Pradeep Chowdary and
9. Dr. Chandrasekhar Rao Simhadri
The objects of the Net Proceeds of the Issue are:
1. Augmenting additional working capital requirements;
2. General Corporate Purposes.
| IPO Opening Date | Sep 25, 2017 |
| IPO Closing Date | Sep 27, 2017 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹50 per equity share |
| Market Lot | 3000 Shares |
| Min Order Quantity | 3000 Shares |
| Listing At | BSE SME |
| Issue Size | 1,512,000 Eq Shares of ₹10 (aggregating up to ₹7.56 Cr) |
The Vanta Bioscience IPO market lot size is 3000 shares. A retail-individual investor can apply for up to 1 lots (3000 shares or ₹150,000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 3000 | ₹150,000 |
| Maximum | 1 | 3000 | ₹150,000 |
Simply avoid this issue as it has no track records. Read detail review...
The Vanta Bioscience IPO is subscribed times on 9/27/2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|
| Listing Date | Friday, October 6, 2017 |
| BSE Script Code | 540729 |
| NSE Symbol | |
| Listing In | M Group of Securities |
| ISIN | INE695X01011 |
| IPO Price | ₹50 per equity share |
| Face Value | ₹10 per equity share |
|
|
Vanta Bioscience Ltd
NO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay Complex,
Rasoolpura, Secunderabad,
Hyderabad – 500 003
Phone: +91 40 6657 5454
Email: info@vantabio.com
Website: http://www.vantabio.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
Vanta Bioscience IPO is a SME IPO of 1,512,000 equity shares of the face value of ₹10 aggregating up to ₹7.56 Crores. The issue is priced at ₹50 per equity share. The minimum order quantity is 3000 Shares.
The IPO opens on Sep 25, 2017, and closes on Sep 27, 2017.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
The Vanta Bioscience IPO opens on Sep 25, 2017 and closes on Sep 27, 2017.
Vanta Bioscience IPO lot size is 3000 Shares and the minimum order quantity is 3000 Shares.
You can apply in Vanta Bioscience IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Vanta Bioscience IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Vanta Bioscience IPO allotment status.
Useful Articles
Top Contributor (300+ Posts, 200+ Likes)
Hope to list in premium.